Vignali, Debora <br/><br/>
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.  [electronic resource] 

 -  Transplantation  09 2016 
 - 1853-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0000000000001276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allografts<br/>Antibodies, Monoclonal--adverse effects<br/>Basiliximab<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Diabetes Mellitus, Type 1--diagnosis<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Forkhead Transcription Factors--blood<br/>Humans<br/>Immunologic Memory--drug effects<br/>Immunosuppressive Agents--adverse effects<br/>Interleukin Receptor Common gamma Subunit--immunology<br/>Interleukin-2 Receptor alpha Subunit--blood<br/>Interleukin-7--pharmacology<br/>Interleukin-7 Receptor alpha Subunit--immunology<br/>Islets of Langerhans Transplantation--adverse effects<br/>Lymphocyte Depletion--methods<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--therapeutic use<br/>Recombinant Fusion Proteins--adverse effects<br/>Signal Transduction--drug effects<br/>Sirolimus--therapeutic use<br/>T-Lymphocytes, Regulatory--drug effects<br/>Tacrolimus--therapeutic use<br/>Time Factors<br/>Treatment Outcome